Suppliers · Not classified · Agricultural biotech & AgTech
Benchmark Holdings
Benchmark’s mission is to drive sustainability in aquaculture by developing solutions in advanced nutrition and health across the aquaculture production cycle which improve yield, quality and animal health and welfare. Our aim is to be aquaculture’s leading supplier of sustainable solutions in genetics, health and advanced nutrition.
Profile
- Industry
- Fishery & aquaculture, Seeds & genetics
- Topics
- Shrimp/fish genetics & aquaculture tech
- Role
- Not classified
- Why it is bioeconomy
- Benchmark Holdings is an aquaculture biotechnology company providing advanced nutrition and health solutions for the aquaculture industry.
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
News & status 6
- 2025-08 Latest status: The company changed its name from Benchmark Holdings plc to Benchmark Holdings Limited and delisted from AIM and Euronext Growth Oslo in August 2025. ↗ ↗ ↗
- 2025-07-25 Result of Tender Offer - Replacement | Company Announcement | InvestegateBenchmark Holdings plc conducted a tender offer, purchasing 127,720,171 ordinary shares (all tendered), cancelling them and returning about £31.9 million to shareholders. After the cancellation, total outstanding shares will be 614,702,942 with voting rights …
- 2025-08-18 Sheffield tech firm quits London Stock Exchange after £32m moveBenchmark Holdings plc, a Sheffield biotechnology firm, has delisted from the London Stock Exchange and Euronext Growth Oslo to re-register as a private company, returning around £95m to shareholders after previously selling its genetics business. The move, …
- 2025-07-25 Benchmark Holdings will pay £31.9m to stakeholders in buy-back offerBenchmark Holdings is moving from a public listing to a private company after a buy-back of up to 226.9m shares; it bought back 127.7m shares for £31.9m, with those shares to be cancelled, increasing the combined stake of its three biggest holders (Ferd AS, …
- 2025-06-12 Genetics operation sale nets £76m profit for biotech business | TheBusinessDesk.comBenchmark Holdings, a Sheffield-based aquaculture biotechnology company, reported a £76m group profit for the six months to 31 March 2025, driven by a £90.9m gain from selling its Genetics operation and ongoing cost-cutting after de-listing from AIM and …
- 2025-05-23 Benchmark planning a £56.7m share buy-back and exit from stock marketsBenchmark Holdings plans to de-list from AIM and Oslo, buy back about £56.7m of shares and issue a special dividend as it re-registers as a private company after selling its genetics division for £230m to Novo Holdings, leaving two remaining segments (Health …
- 2025-05-23 Benchmark Holdings to delist following £260 million sale of Genetics arm | Salmon BusinessBenchmark Holdings is planning to delist from AIM and Euronext Growth after selling its aquaculture genetics division to Novo Holdings for £260 million, and will convert to a private company with plans to return proceeds to shareholders. The move follows a …
Network: owners, partners, peers
Ownership & investors 1
| investor | Novo Holdings A/S |
Similar companies
AquaGen · INVE Aquaculture · Landcatch Natural Selection · STIM · Aqua Pharma Group · PatoGen AS · GenoMar Genetics · PHARMAQ Analytiq AS
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member